Skip to content

Mirum Pharmaceuticals

US · MIRM #2051 by market cap Listed 2019
96.13 +0.62 +0.65%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 12 analysts

Buy
Avg price target 158.82 +65.2%
Price target rangecurrent 96.13
Low130.00
Avg158.82
High202.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 Citi -- Buy 194.00
2026-11-11 H.C. Wainwright -- Buy 202.00
2026-11-10 Citi -- Buy 194.00
2026-11-09 Citi -- Buy 184.00
2026-11-09 J.P. Morgan -- Buy --
2026-11-05 Morgan Stanley -- Buy 152.00
2026-11-05 Leerink Partners -- Buy 140.00
2026-11-04 Citizens JMP -- Buy 167.00
2026-11-04 Stifel -- Buy 156.00
2026-11-04 H.C. Wainwright -- Buy 202.00
2026-11-03 TD Cowen -- Buy 145.00
2026-11-03 Cantor Fitzgerald -- Buy 160.00
2026-11-03 RBC Capital -- Buy 155.00
2026-10-27 H.C. Wainwright -- Buy 200.00
2026-10-21 TD Cowen -- Buy 145.00
2026-10-15 Stifel -- Buy 156.00
2026-10-14 Stifel -- Buy 156.00
2026-10-13 Morgan Stanley -- Buy 152.00
2026-10-13 Evercore -- Buy 146.00
2026-10-13 Citi -- Buy 184.00
2026-10-12 Morgan Stanley -- Buy 152.00
2026-10-12 Citi -- Buy 184.00
2026-10-12 H.C. Wainwright -- Buy 200.00
2026-10-12 J.P. Morgan -- Buy --
2026-10-08 H.C. Wainwright -- Buy 195.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 After close ±10.62% +11.42% (beat)
2026/Q2 2026-08-05 After close ±9.27% -11.04% (beat)
2026/Q1 2026-05-06 After close ±6.10% -6.50% (beat)
2025/Q4 2026-02-25 After close ±8.08% -15.13% (beat)
2025/Q3 2025-11-04 After close ±9.62% -1.24% (in line)
2025/Q2 2025-08-06 After close ±9.40% +12.04% (beat)
2025/Q1 2025-05-07 After close ±8.61% +9.75% (beat)
2024/Q4 2025-02-26 After close ±12.69% -7.02% (in line)
2024/Q3 2024-11-12 -- -- +1.61%
2024/Q2 2024-08-07 After close ±14.68% +2.34% (in line)
2024/Q1 2024-05-08 After close ±8.59% +3.16% (in line)
2023/Q4 2024-02-28 After close ±20.04% -0.62% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Mirum Pharmaceuticals discussion 0 comments

Add a comment